Literature DB >> 20818110

Synchronous resection of solitary liver metastases with pancreaticoduodenectomy.

Amanjeet Singh1, Tanveer Singh, Adarsh Chaudhary.   

Abstract

CONTEXT: There is limited information available about the feasibility and benefits of synchronous resection of liver metastases in patients with pancreatic and periampullary cancer undergoing pancreaticoduodenectomy.
OBJECTIVE: We report on our experience with 7 such patients.
DESIGN: Analysis of the prospective database was carried out to identify patients who underwent synchronous resection of liver metastases with pancreaticoduodenectomy. PATIENTS: Two-hundred and thirty patients underwent pancreaticoduodenectomy for pancreatic and periampullary cancer in our unit between September 2003 and September 2009. MAIN OUTCOME MEASURES: The primary aim of our study was to determine the survival benefits and the secondary aim was to evaluate their safety and influence on the results of a pancreaticoduodenectomy.
RESULTS: Seven patients (3%) underwent synchronous resection of a solitary liver metastasis. In these patients, the operative time and intra-operative blood loss was marginally high as compared to the overall cohort of patients undergoing pancreaticoduodenectomy; however, the complication rates and the duration of the hospital stay were not affected. In patients undergoing resection of liver metastasis, there were 4 recurrences over a mean follow-up of 21 months.
CONCLUSIONS: In patients with resectable pancreatic and periampullary cancer, the resection of a solitary liver metastasis can safely be performed together with a pancreaticoduodenectomy; however, its impact on improving survival has yet to be proven.

Entities:  

Mesh:

Year:  2010        PMID: 20818110

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  15 in total

Review 1.  Liver regeneration biology: Implications for liver tumour therapies.

Authors:  Christopher Hadjittofi; Michael Feretis; Jack Martin; Simon Harper; Emmanuel Huguet
Journal:  World J Clin Oncol       Date:  2021-12-24

2.  Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-Volume Peritoneal Metastasis: Results from a Prospective Pilot Study.

Authors:  Travis E Grotz; Jennifer A Yonkus; Cornelius A Thiels; Susanne G Warner; Robert R McWilliams; Amit Mahipal; Tanios S Bekaii-Saab; Sean P Cleary; Michael L Kendrick; Mark J Truty
Journal:  Ann Surg Oncol       Date:  2022-08-16       Impact factor: 4.339

Review 3.  [Oligometastasis in pancreatic cancer : Current state of knowledge and spectrum of local therapy].

Authors:  F Gebauer; A I Damanakis; C Bruns
Journal:  Chirurg       Date:  2018-07       Impact factor: 0.955

Review 4.  Surgery for oligometastasis of pancreatic cancer.

Authors:  Fengchun Lu; Katherine E Poruk; Matthew J Weiss
Journal:  Chin J Cancer Res       Date:  2015-08       Impact factor: 5.087

5.  Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma.

Authors:  Younghwan Kim; Song Cheol Kim; Ki Byoung Song; Jayoun Kim; Dae Ryong Kang; Jae Hoon Lee; Kwang-Min Park; Young-Joo Lee
Journal:  HPB (Oxford)       Date:  2016-02-08       Impact factor: 3.647

6.  Surgery for Li Fraumeni syndrome: pushing the limits of surgical oncology.

Authors:  Russell C Langan; Kiran H Lagisetty; Scott Atay; Prakash Pandalai; Alexander Stojadinovic; Udo Rudloff; Itzhak Avital
Journal:  Am J Clin Oncol       Date:  2015-02       Impact factor: 2.339

Review 7.  Multimodality therapy in metastatic pancreas cancer with a BRCA mutation and durable long-term outcome: biology, intervention, or both?

Authors:  Thomas L Sutton; Aaron Grossberg; Frederick Ey; Eileen M O'Reilly; Brett C Sheppard
Journal:  Cancer Biol Ther       Date:  2021-10-25       Impact factor: 4.742

8.  A long-term survival case treated with conversion surgery following chemotherapy after diagnostic metastasectomy for pancreatic cancer with synchronous liver metastasis.

Authors:  Mitsuhiro Shimura; Masamichi Mizuma; Hiroki Hayashi; Akiko Mori; Tomoyoshi Tachibana; Tatsuo Hata; Masahiro Iseki; Tatsuyuki Takadate; Kyohei Ariake; Shimpei Maeda; Hideo Ohtsuka; Naoaki Sakata; Takanori Morikawa; Kei Nakagawa; Takeshi Naitoh; Takashi Kamei; Fuyuhiko Motoi; Michiaki Unno
Journal:  Surg Case Rep       Date:  2017-12-29

9.  Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?

Authors:  Natasha Leigh; Daniel Solomon; Eric Pletcher; Daniel M Labow; Deepa R Magge; Umut Sarpel; Benjamin J Golas
Journal:  World J Surg Oncol       Date:  2020-06-11       Impact factor: 2.754

10.  Brain metastasis in pancreatic cancer.

Authors:  Johannes Lemke; Jan Scheele; Thomas Kapapa; Christian Rainer Wirtz; Doris Henne-Bruns; Marko Kornmann
Journal:  Int J Mol Sci       Date:  2013-02-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.